Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Alligator Bioscience AB ( (SE:ATORX) ) has shared an announcement.
Alligator Bioscience AB has announced the exercise price for its warrants series TO 13, set at SEK 3.12, with the exercise period running from 1 September 2025 to 15 September 2025. This development follows a rights issue and a reverse share split, with the potential to raise approximately SEK 30.6 million if all warrants are exercised, impacting the company’s financial positioning and offering opportunities for stakeholders to subscribe to new ordinary shares.
More about Alligator Bioscience AB
Alligator Bioscience AB is a company operating in the biotechnology industry, focusing on the development of innovative antibody-based therapies for cancer treatment. The company is based in Lund, Sweden, and is known for its research and development efforts in immuno-oncology.
Average Trading Volume: 440,847
Technical Sentiment Signal: Sell
Current Market Cap: SEK151M
See more data about ATORX stock on TipRanks’ Stock Analysis page.